Plasma Levels of Polyunsaturated Fatty Acids and Adverse Kidney Outcomes
Authors:
- 28 February 2024
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 84 (2) , 179-194.e1
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular RiskJAMA, 2020
- Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 DiabetesJAMA, 2019
- Chronic Kidney Disease and Coronary Artery DiseaseJACC, 2019
- Omega-6 fatty acids and inflammationProstaglandins, Leukotrienes and Essential Fatty Acids, 2018
- The Economic Burden of Chronic Kidney Disease and End-Stage Renal DiseaseSeminars in Nephrology, 2016
- Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery diseaseAtherosclerosis, 2016
- Reverse association of omega-3/omega-6 polyunsaturated fatty acids ratios with carotid atherosclerosis in patients on hemodialysisAtherosclerosis, 2016
- Fatty acid composition of plasma, blood cells and whole blood: Relevance for the assessment of the fatty acid status in humansProstaglandins, Leukotrienes and Essential Fatty Acids, 2007
- IN VITRO EFFECTS OF EICOSANOIDS DERIVED FROM DIFFERENT 20-CARBON FATTY ACIDS ON PRODUCTION OF MONOCYTE-DERIVED CYTOKINES IN HUMAN WHOLE BLOOD CULTURESCytokine, 2002
- Endogenous Anti-inflammatory Mediators from Arachidonate in Human NeutrophilsBiochemical and Biophysical Research Communications, 2002